Inventor · disambiguated record
Xueyan Wang
Also filed as: WANG XUEYAN
11 granted patents·6 pending applications·88 citations·filing 2009–2022
89Inventor score
Files withCYMABAY THERAPEUTICS INC9PH PHARMA CO LTD2CHENGDU PRECISOME BIOTECHNOLOGY CO LTD1CORREGENE BIOTECHNOLOGY CO LTD1METABOLEX INC1
Top patents by PatentIndex Score
17 records- 0196US9616039B2Treatment of NAFLD and NASHCYMABAY THERAPEUTICS INC·Filed 2016·Granted Apr 11, 2017·31 cites·12 claims
- 0296US9381181B2Treatment of NAFLD and NASHCYMABAY THERAPEUTICS INC·Filed 2015·Granted Jul 5, 2016·38 cites·6 claims
- 0391US10188620B2Treatment for NAFLD and NASHCYMABAY THERAPEUTICS INC·Filed 2018·Granted Jan 29, 2019·7 cites·19 claims
- 0491US9962346B2Treatment of NAFLD and NASHCYMABAY THERAPEUTICS INC·Filed 2017·Granted May 8, 2018·8 cites·13 claims
- 0586US10722483B2Treatment of NAFLD and NASHCYMABAY THERAPEUTICS INC·Filed 2019·Granted Jul 28, 2020·1 cites·19 claims
- 0686US10342770B2Treatment of NAFLD and NASHCYMABAY THERAPEUTICS INC·Filed 2018·Granted Jul 9, 2019·3 cites·19 claims
- 0773US11179359B2Treatment of NAFLD and NASHCYMABAY THERAPEUTICS INC·Filed 2020·Granted Nov 23, 2021·0 cites·19 claims
- 0869US11007162B2Methods of reducing small, dense LDL particlesCYMABAY THERAPEUTICS INC·Filed 2018·Granted May 18, 2021·0 cites·10 claims
- 0966US10806735B2Use of neutrophil elastase inhibitors in liver diseasePH PHARMA CO LTD·Filed 2019·Granted Oct 20, 2020·0 cites·4 claims
- 1063US2010152295A1Methods of reducing small, dense ldl particlesMETABOLEX INC·Filed 2009·Application pending·0 cites
- 1158US2021069192A1Use of neutrophil elastase inhibitors in liver diseasePH PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 1256US2024424101A1Antigen binding proteins and uses thereofCORREGENE BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
- 1347US2016324811A1Methods of reducing small, dense ldl particlesCYMABAY THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1445US2023285430A1Spiroindolone compositions and methods for the treatment of malariaNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1541US2018271792A1Oral delivery of physiologically active substancesREZOLUTE INC·Filed 2018·Application pending·0 cites
- 1637US8703776B2Agonists of GPR131 and uses thereofNOVACK AARON ROBERT·Filed 2012·Granted Apr 22, 2014·0 cites·20 claims
- 1731US12071611B2Rare cell capture system and application thereofCHENGDU PRECISOME BIOTECHNOLOGY CO LTD·Filed 2019·Granted Aug 27, 2024·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Xueyan Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →